Skip to main content
. Author manuscript; available in PMC: 2024 Apr 30.
Published in final edited form as: Nat Immunol. 2021 Dec 22;23(1):75–85. doi: 10.1038/s41590-021-01093-y

Extended Data Fig. 3 |. Cytokine and mRNA changes associated with iRHOM2 deficiency.

Extended Data Fig. 3 |

(a) Heat map of multiplex measurements of 48 cytokine levels in HC plasma using the Luminex system. (b) Volcano plot of whole blood RNA-seq showing upregulated genes (red) and down regulated genes (blue) in the patient sample from iRHOM2 deficient patients compared to HC. (c) GSEA based on the patient whole blood RNA-seq data in comparison to healthy control. NES; normalized enrichment score. (d) Table of ADAM17 regulated molecules extracted from whole blood RNA-seq. (e) Volcano plot of gene expression with fold difference between log2 normalized expression shown in Fig. 5d versus −log10 adjusted P-value in whole blood. Vertical grey lines indicate fold changes, with a cut off ±2. The horizontal line represents a p-value of 1−10. (f) Similar with Fig. 5f, volcano plot of gene expression before and after 3 hours stimulation in T cells from 4 HC (left panel) and 4 patients (right panel). Red dots represent upregulated mRNAs and blue dots indicate downregulated mRNAs. (g) Hierarchical clustering of stimulated T cells RNA-seq data in the different time points using HC samples. Time is shown on the x-axis and gene expression levels are shown on the y-axis. Mean expression was used from 4 HC samples. Statistical significance was calculated by using the Wald test for hypothesis testing (b, e, f).